{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T05:41:19Z","timestamp":1693546879094},"reference-count":12,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2002,12,9]],"date-time":"2002-12-09T00:00:00Z","timestamp":1039392000000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> The haematological and serological responses of Waldenstr\u00f6m's macroglobulinaemia (WM) to rituximab have been recently reported, but there have been few reports examining the genetic responses of the drug in the treatment of WM. We report here a case of WM associated with deletion 13q14 and JH gene rearrangement that was successfully treated with rituximab alone. Three months after the therapy, the patient achieved haematological remission with the disappearance of constitutional symptoms and chromosomal abnormalities; however, the remission was partial, because the serum monoclonal immunoglobulin M and JH gene rearrangement persisted. Our case demonstrates that first\u2010line therapy with rituximab is clinically and cytogenetically beneficial for WM.<\/jats:p>","DOI":"10.1034\/j.1600-0609.2002.02828.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T18:53:57Z","timestamp":1047408837000},"page":"321-323","source":"Crossref","is-referenced-by-count":2,"title":["Effects of rituximab on a patient with Waldenstr\u00f6m's macroglobulinaemia with deletion 13q14"],"prefix":"10.1034","volume":"69","author":[{"given":"Akinori","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun\u2010Ichi","family":"Tamaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,9]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2780"},{"key":"e_1_2_4_3_2","first-page":"279b","article-title":"Waldenstr\u00f6m's macroglobulinemia: a prospective study comparing daily versus intermittent oral chlorambucil","volume":"92","author":"Kyle RA","year":"1998","journal-title":"Blood"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2060"},{"key":"e_1_2_4_5_2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC\u2010C2B8: results of a phase I multiple\u2010dose trial in patients with relapsed non\u2010Hodgkin's lymphoma","volume":"15","author":"Maloney DG","year":"1997","journal-title":"J Clin Oncol"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.317"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008350208019"},{"key":"e_1_2_4_9_2","first-page":"125a","article-title":"Phenotypic and clinical evidence supports Rituximab for Waldenstr\u00f6m's macroglobulinemia","volume":"94","author":"Weber DM","year":"1999","journal-title":"Blood"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200105000-00012"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.039"},{"key":"e_1_2_4_12_2","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer N","year":"2000","journal-title":"Blood"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(01)00526-X"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2002.02828.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0609.2002.02828.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T08:06:54Z","timestamp":1693469214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0609.2002.02828.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":12,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1034\/j.1600-0609.2002.02828.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0609.2002.02828.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}